A citation-based method for searching scientific literature

Caitlin T Fierheller, Laure Guitton-Sert, Wejdan M Alenezi, Timothée Revil, Kathleen K Oros, Yuandi Gao, Karine Bedard, Suzanna L Arcand, Corinne Serruya, Supriya Behl, Liliane Meunier, Hubert Fleury, Eleanor Fewings, Deepak N Subramanian, Javad Nadaf, Jeffrey P Bruce, Rachel Bell, Diane Provencher, William D Foulkes, Zaki El Haffaf, Anne-Marie Mes-Masson, Jacek Majewski, Trevor J Pugh, Marc Tischkowitz, Paul A James, Ian G Campbell, Celia M T Greenwood, Jiannis Ragoussis, Jean-Yves Masson, Patricia N Tonin. Genome Med 2021
Times Cited: 2

List of co-cited articles
1 articles co-cited >1

Times Cited
  Times     Co-cited

Integrated analysis of germline and somatic variants in ovarian cancer.
Krishna L Kanchi, Kimberly J Johnson, Charles Lu, Michael D McLellan, Mark D M Leiserson, Michael C Wendl, Qunyuan Zhang, Daniel C Koboldt, Mingchao Xie, Cyriac Kandoth,[...]. Nat Commun 2014

Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex.
Eunyoung Jeong, Seong-Gyu Lee, Hyun-Suk Kim, Jihyeon Yang, Jinwoo Shin, Youngran Kim, Jihan Kim, Orlando D Schärer, Youngjin Kim, Jung-Eun Yeo,[...]. Nucleic Acids Res 2020

Ovarian cancer transformation from adenocarcinoma to undifferentiated small cell carcinoma: A case report.
Zuo Ping Huang, Xing Jing Liu, Bin Xin Zou, Qian Shen, Ying Liu, Tao Zhou. Oncol Lett 2015

The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy.
L C Hanker, S Loibl, N Burchardi, J Pfisterer, W Meier, E Pujade-Lauraine, I Ray-Coquard, J Sehouli, P Harter, A du Bois. Ann Oncol 2012

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.
Bella Kaufman, Ronnie Shapira-Frommer, Rita K Schmutzler, M William Audeh, Michael Friedlander, Judith Balmaña, Gillian Mitchell, Georgeta Fried, Salomon M Stemmer, Ayala Hubert,[...]. J Clin Oncol 2015

A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.
David C Wilkes, Verena Sailer, Hui Xue, Hongwei Cheng, Colin C Collins, Martin Gleave, Yuzhuo Wang, Francesca Demichelis, Himisha Beltran, Mark A Rubin,[...]. Cold Spring Harb Mol Case Stud 2017

Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study.
Wassim Abida, David Campbell, Akash Patnaik, Jeremy D Shapiro, Brieuc Sautois, Nicholas J Vogelzang, Eric G Voog, Alan H Bryce, Ray McDermott, Francesco Ricci,[...]. Clin Cancer Res 2020

Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection.
Wungki Park, Jiapeng Chen, Joanne F Chou, Anna M Varghese, Kenneth H Yu, Winston Wong, Marinela Capanu, Vinod Balachandran, Caitlin A McIntyre, Imane El Dika,[...]. Clin Cancer Res 2020

Epithelial ovarian cancer.
Stephanie Lheureux, Charlie Gourley, Ignace Vergote, Amit M Oza. Lancet 2019

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016

Niraparib in ovarian cancer: results to date and clinical potential.
Davide Caruso, Anselmo Papa, Silverio Tomao, Patrizia Vici, Pierluigi Benedetti Panici, Federica Tomao. Ther Adv Med Oncol 2017

Rare variants in FANCA induce premature ovarian insufficiency.
Xi Yang, Xiaojin Zhang, Jiao Jiao, Feng Zhang, Yuncheng Pan, Qiqi Wang, Qing Chen, Baozhu Cai, Shuyan Tang, Zixue Zhou,[...]. Hum Genet 2019

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes.
Darren R Hodgson, Brian A Dougherty, Zhongwu Lai, Anitra Fielding, Lynda Grinsted, Stuart Spencer, Mark J O'Connor, Tony W Ho, Jane D Robertson, Jerry S Lanchbury,[...]. Br J Cancer 2018

FANCA Promotes DNA Double-Strand Break Repair by Catalyzing Single-Strand Annealing and Strand Exchange.
Anaid Benitez, Wenjun Liu, Anna Palovcak, Guanying Wang, Jaewon Moon, Kevin An, Anna Kim, Kevin Zheng, Yu Zhang, Feng Bai,[...]. Mol Cell 2018

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
Kathleen N Moore, Angeles Alvarez Secord, Melissa A Geller, David Scott Miller, Noelle Cloven, Gini F Fleming, Andrea E Wahner Hendrickson, Masoud Azodi, Paul DiSilvestro, Amit M Oza,[...]. Lancet Oncol 2019

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Joaquin Mateo, Nuria Porta, Diletta Bianchini, Ursula McGovern, Tony Elliott, Robert Jones, Isabel Syndikus, Christy Ralph, Suneil Jain, Mohini Varughese,[...]. Lancet Oncol 2020

Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?
Federica Tomao, Maurizio D'Incalci, Elena Biagioli, Fedro A Peccatori, Nicoletta Colombo. Cancer 2017

Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition.
Nuala McCabe, Nicholas C Turner, Christopher J Lord, Katarzyna Kluzek, Aneta Bialkowska, Sally Swift, Sabrina Giavara, Mark J O'Connor, Andrew N Tutt, Małgorzata Z Zdzienicka,[...]. Cancer Res 2006

Serum CA125, CA199 and CEA Combined Detection for Epithelial Ovarian Cancer Diagnosis: A Meta-analysis.
Junhong Guo, Jiangtao Yu, Xiaojie Song, Haixia Mi. Open Med (Wars) 2017

A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer.
Ella Thompson, Rebecca L Dragovic, Sally-Anne Stephenson, Diana M Eccles, Ian G Campbell, Alexander Dobrovic. BMC Cancer 2005

The intronic BRCA1 c.5407-25T>A variant causing partly skipping of exon 23-a likely pathogenic variant with reduced penetrance?
Hildegunn Høberg-Vetti, Elisabet Ognedal, Adrien Buisson, Tone Bøe Aaman Vamre, Sarah Ariansen, Jacqueline M Hoover, Geir Egil Eide, Gunnar Houge, Torunn Fiskerstrand, Bjørn Ivar Haukanes,[...]. Eur J Hum Genet 2020

Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes.
Tyler Landrith, Bing Li, Ashley A Cass, Blair R Conner, Holly LaDuca, Danielle B McKenna, Kara N Maxwell, Susan Domchek, Nichole A Morman, Christopher Heinlen,[...]. NPJ Precis Oncol 2020

Pathology update to the Manchester Scoring System based on testing in over 4000 families.
D Gareth Evans, Elaine F Harkness, Inga Plaskocinska, Andrew J Wallace, Tara Clancy, Emma R Woodward, Tony A Howell, Marc Tischkowitz, Fiona Lalloo. J Med Genet 2017

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018

CADD-Splice-improving genome-wide variant effect prediction using deep learning-derived splice scores.
Philipp Rentzsch, Max Schubach, Jay Shendure, Martin Kircher. Genome Med 2021

Comprehensive comparison of three commercial human whole-exome capture platforms.
Asan, Yu Xu, Hui Jiang, Chris Tyler-Smith, Yali Xue, Tao Jiang, Jiawei Wang, Mingzhi Wu, Xiao Liu, Geng Tian,[...]. Genome Biol 2011

Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift.
Pål Møller, Mev Dominguez-Valentin, Einar Andreas Rødland, Eivind Hovig. Cancers (Basel) 2019

Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction.
Barbara Wappenschmidt, Alexandra A Becker, Jan Hauke, Ute Weber, Stefanie Engert, Juliane Köhler, Karin Kast, Norbert Arnold, Kerstin Rhiem, Eric Hahnen,[...]. PLoS One 2012

RNA and disease.
Thomas A Cooper, Lili Wan, Gideon Dreyfuss. Cell 2009

Identification of Deep-Intronic Splice Mutations in a Large Cohort of Patients With Inherited Retinal Diseases.
Xinye Qian, Jun Wang, Meng Wang, Austin D Igelman, Kaylie D Jones, Yumei Li, Keqing Wang, Kerry E Goetz, David G Birch, Paul Yang,[...]. Front Genet 2021

Multiple splicing defects in an intronic false exon.
H Sun, L A Chasin. Mol Cell Biol 2000

Use of deep whole-genome sequencing data to identify structure risk variants in breast cancer susceptibility genes.
Xingyi Guo, Jiajun Shi, Qiuyin Cai, Xiao-Ou Shu, Jing He, Wanqing Wen, Jamie Allen, Paul Pharoah, Alison Dunning, David J Hunter,[...]. Hum Mol Genet 2018

Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients.
Greet Wieme, Jan Kral, Toon Rosseel, Petra Zemankova, Bram Parton, Michal Vocka, Mattias Van Heetvelde, Petra Kleiblova, Bettina Blaumeiser, Jana Soukupova,[...]. Cancers (Basel) 2021

Nonsense-mediated mRNA decay in humans at a glance.
Tatsuaki Kurosaki, Lynne E Maquat. J Cell Sci 2016

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017

Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.
Hilmi Ozcelik, Xuejiang Shi, Martin C Chang, Eric Tram, Matt Vlasschaert, Nando Di Nicola, Anna Kiselova, Denise Yee, Aaron Goldman, Mark Dowar,[...]. J Mol Diagn 2012

Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence.
Qiao Wang, Hongling Peng, Xiaorong Qi, Min Wu, Xia Zhao. Signal Transduct Target Ther 2020

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Mary B Daly, Robert Pilarski, Matthew B Yurgelun, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Judy E Garber,[...]. J Natl Compr Canc Netw 2020

The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease.
Paulo J da Costa, Juliane Menezes, Luísa Romão. Int J Biochem Cell Biol 2017

Effective variant filtering and expected candidate variant yield in studies of rare human disease.
Brent S Pedersen, Joe M Brown, Harriet Dashnow, Amelia D Wallace, Matt Velinder, Martin Tristani-Firouzi, Joshua D Schiffman, Tatiana Tvrdik, Rong Mao, D Hunter Best,[...]. NPJ Genom Med 2021

Hereditary breast and ovarian cancer: new genes in confined pathways.
Finn Cilius Nielsen, Thomas van Overeem Hansen, Claus Storgaard Sørensen. Nat Rev Cancer 2016

Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer.
Marina Pavanello, Isaac Hy Chan, Amir Ariff, Paul Dp Pharoah, Simon A Gayther, Susan J Ramus. Cancers (Basel) 2020

Characterization and in silico analyses of the BRCA1/2 variants identified in individuals with personal and/or family history of BRCA-related cancers.
Dilek Pirim, Niyazi Kaya, Elif Uz Yıldırım, Sebnem Ozemri Sag, Sehime Gulsun Temel. Int J Biol Macromol 2020

BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway.
Cecilie Heramb, Teresia Wangensteen, Eli Marie Grindedal, Sarah Louise Ariansen, Sheba Lothe, Ketil Riddervold Heimdal, Lovise Mæhle. Hered Cancer Clin Pract 2018

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.